Home LiteratureArticle Details
PMID: 11829604 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Quantitative measurements of recombinant HIV surface glycoprotein 120 binding to several glycosphingolipids expressed in planar supported lipid bilayers.

Journal of the American Chemical Society ·Vol. 124 ·No. 6 ·2002-02-13 ·Pages 968-77

Conboy JC, McReynolds KD, Gervay-Hague J, Saavedra SS

Abstract

The interaction of recombinant HIV-1 surface glycoprotein gp120 (rgp120) with natural isolates of lactosylceramide (LacCer), glucosylceramide (GlcCer), and galactosylceramide (GalCer) has been quantitatively measured under equilibrium conditions using total internal reflection fluorescence (TIRF) spectroscopy. The binding affinity (K(a)) of rgp120 to these glycosphingolipids (GSLs), reconstituted at 5 mol % in supported planar lipid bilayers composed of 95 mol % POPC, is ca. 10(6) M(-1) for dissolved rgp120 concentrations greater than 25 nM. In contrast, at concentrations of rgp120 between 0.2 and 15 nM, rgp120 does not bind significantly to LacCer and GlcCer, but has a high affinity for GalCer with a measured K(a) value of 1.6 x 10(9) M(-1). However, protein surface coverage measurements show that this strong binding process accounts for very little of the total protein adsorbed over the entire concentration range studied. At a protein concentration of ca. 20 nM, the surface coverage is only 3% of that achieved at apparent saturation (i.e., when the protein concentration is ca. 220 nM). Thus the "high affinity" binding sites comprise only a small fraction of the total number of binding sites. Several other variables were investigated. Rgp120 binding behavior at membranes doped with alpha-hydroxygalactosylceramide (alpha-GalCer) was very similar to that observed with GalCer, showing that the presence/absence of an alpha-hydroxy moiety does not significantly affect galactosylceramide recognition. Phase segregation of GalCer, which occurs when the mole fraction of this GSL in a POPC bilayer exceeds ca. 0.1, was also investigated and showed no effect on binding affinity at low rgp120 concentrations. To investigate the influence of fatty acid chain length, GSLs with monodisperse C(18) and C(24) chain lengths, both with and without an alpha-hydroxy moiety, were synthesized, and their binding affinity to rgp120 was examined. Relative to the natural isolates (which contain a mixture of chain lengths), minimal differences were observed; thus among the compounds tested, fatty acid chain length does not affect GSL recognition. The results of this work should aid efforts to design anti-HIV-1 agents based on membrane-tethered, carbohydrate-based receptors for rgp120.

MeSH Terms
Antigens, CD Ceramides/metabolism Galactosylceramides/metabolism Glucosylceramides/metabolism HIV Envelope Protein gp120/metabolism Hydroxylation Kinetics Lactosylceramides/metabolism Lipid Bilayers/metabolism Membranes/metabolism Protein Binding Recombinant Proteins/metabolism
Chemicals
Antigens, CD Ceramides Galactosylceramides Glucosylceramides HIV Envelope Protein gp120 Lactosylceramides Lipid Bilayers Recombinant Proteins CDw17 antigen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Conboy John C
Department of Chemistry, University of Arizona, Tucson, Arizona 85721-0041, USA.
McReynolds Katherine D
Gervay-Hague Jacquelyn
Saavedra S Scott
Article Info
Journal
Journal of the American Chemical Society
Abbr.
J Am Chem Soc
ISSN
0002-7863
Published
2002-02-13
Pages
968-77
Language
English
Region
United States
NLM ID
7503056
Subset
IM
Grants
NIAID NIH HHS · AI40359-02 · United States
NIGMS NIH HHS · F32 GM19914 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]